SeaBridge Investment Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-40
Closed -$7K 268
2017
Q3
$7K Hold
40
﹤0.01% 240
2017
Q2
$4K Hold
40
﹤0.01% 249
2017
Q1
$3K Hold
40
﹤0.01% 250
2016
Q4
$2K Buy
+40
New +$1.96K ﹤0.01% 246

SeaBridge Investment Advisors's KITE Position: Q4 2017 in Review

SeaBridge Investment Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 40 shares — an estimated $7K sold.

SeaBridge Investment Advisors first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $7K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • SeaBridge Investment Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • SeaBridge Investment Advisors sold 40 Kite Pharma, Inc. shares in Q4 2017, an estimated $7K.
  • SeaBridge Investment Advisors first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
  • SeaBridge Investment Advisors's Kite Pharma, Inc. position peaked at $7K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on SeaBridge Investment Advisors's 13F filing for Q4 2017, filed 23 Jan 2018.